Pay in 4 interest-free payments of $5.61 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Combinations with GPX4 inhibition leads to ferroptosis in ER+ breast cancer models, and the triplet combination of palbociclib, giredestrant, and GPX4 inhibition was highly effective in eradicating cancer cells and preventing clonal outgrowth
Connect with Stuart Piltch on LinkedIn
PubMed laboratory research record [PMID: 41773123] PubMed record related to this compound for laboratory literature review
Figure 4 Discussion This meta-analysis is the first large sample study that was designed to assess the relationship between the use of GLP-1 receptor agonists and the occurrence of various thyroid disorders
4AH, R = 0.85, p = 0.007)
Still a trend towards benefit appears promising and a dataset that is one I hope gets repeated now that the GLP-1s are in more wide use and obesity rates are hopefully falling
US$ 25.12
US$ 25.64
US$ 26.97
US$ 24.25
US$ 24.93
US$ 28.44
US$ 27.50
US$ 29.50
US$ 24.28
US$ 22.82
US$ 23.76
